Running title: Myc and RasV12 cells require NR2 to be supercompetitors Banreti and Meier 2 SUMMARY Myc is a major driver of cell growth in many cancers, but direct inhibition of Myc's oncogenic activity has been challenging. Interactions between wild-type and Myc-expressing cells cause Myc cells to acquire 'supercompetitor' behaviour that increases their fitness and enables them to overtake the tissue by killing their wild-type neighbours through TNF-induced cell death during a process called cell competition. Here we report that the competitive behaviour of Myc, RasV12 cells, and normal epithelial cells, critically depends on the NMDA receptor. Myc cells upregulate NMDAR2 (NR2) to gain supercompetitor status and subdue their wild-type neighbours. Pharmacological inhibition or genetic depletion of NR2 changes the supercompetitor status of oncogenic Myc or RasV12 clones into 'superlosers', resulting in their elimination via cell competition by wild-type neighbours in a TNF-dependent manner. Our data demonstrate that that the NMDA receptor (NMDAR) determines cellular fitness during cell competition, and can be targeted to change the fitness landscape of supercompetitive Myc and RasV12 clones, converting them into superlosers.
Introduction
Cell competition is an evolutionary conserved quality control process that eliminates suboptimal, but otherwise viable cells, thereby safeguarding tissue fitness and tissue homeostasis 1 . How relative fitness disparities are measured across groups of cells, and how the decision is taken whether a particular cell will persist in the tissue ('winner cell') or is killed ('loser cell') is not completely understood 2 . This is an important issue as competitive behaviour is exploited by cells with deregulated oncogenes or tumour suppressors, which subsequently expand at the expense of, and with the help from, their cooperating wild-type (WT) neighbours 1 .
Growth signalling pathways involved in metabolic cell competition all seem to funnel through Myc, which functions as an essential signalling hub sustaining growth of many types of cancers. Myc regulates expression of components that control proliferation, cell death, differentiation, and central metabolic pathways. Particularly, acute changes in cellular metabolism appear to be critical for the winner phenotype during Myc supercompetition in Drosophila 3 .
Recent data demonstrate that living tumours can uptake lactate and preferentially utilize it over glucose to fuel TCA cycle and sustain tumour metabolism 4 . Moreover, the growth promoting effect of stromal cells is impaired by glycolytic inhibition, suggesting that the stroma provides nutritional support to malignant cells by transferring lactate from cancer-associated fibroblasts (CAFs) to cancer cells 5, 6 .
Such energy transfer from glycolytic stromal cells to epithelial cancer cells closely resembles physiological processes of metabolic cooperativity, such as in 'neuron-astrocyte metabolic coupling' in the brain, and the 'lactate shuttle' in the skeletal muscle 7, 8 . Activation of glycolysis in astrocytes and MCT-mediated transfer of lactate to neurons supports neuron mitochondrial oxidative phosphorylation and energy demand 9 . These observations raise the intriguing possibility that lactate serves as fuel to complement glucose metabolism in both supercompetitors as well as tumours.
We report here that the NMDA receptor, a key component of the 'learning and memory' module, is repurposed to coordinate the competitiveness of epithelial cells within a tissue. We find that the activity of the NMDAR underpins cellular fitness in Drosophila epithelia during Myc-and RasV12-induced supercompetition, paradigms of cell competition with parallels to mammalian tumour promotion.
Inactivation of NMDAR changes the supercompetitor status of oncogenic Myc or RasV12 clones into 'superlosers', allowing their elimination by surrounding WT cells. Our data are consistent with the notion that NMDAR exerts its effect by regulating metabolic coupling between glycolytic loser and oxidative winner cells, driving loser cells to transfer their carbon fuel (lactate) to their neighbours. Preventing loser cells from 'donating' lactate to their neighbours removes fitness disparities and abrogates NMDARmediated cell competition.
Results

Clonal depletion of NR2 results in the elimination of otherwise viable cells
Genetic studies in Drosophila have revealed that tumour-driven cell competition eliminates nearby wildtype neighbours through TNF-dependent cell death, allowing the expansion of oncogene-induced supercompetitor clones 1, 3, 10 . However, the initial mechanism by which cells acquire supercompetitor status to drive cell competition has remained unknown. To identify components that sense fitness disparities during cell competition, we conducted a candidate-based approach in Drosophila using hetero-(GFP-marked loser clones among winners -genetic mosaic background) and homotypic (GFPmarked loser clones among losers) competition assays in the developing imaginal wing disc ( Figure   1A ). Comparison of clonal survival in hetero-versus homotypic genetic backgrounds allows the exclusion of genes that compromise cell viability in general. In Drosophila, oncogenic polarity-deficient mutant cells for Discs Large 1 (Dlg1) are eliminated by wild-type neighbours through cell competition 11 . Dlg1 is the highly conserved homologue of mammalian PSD-95 and SAP97, which directly bind to the carboxy-terminal tail of NR2B 12, 13 , a subunit of the N-methyl-D-aspartate receptor (NMDAR).
NMDAR is best known for its involvement in neuronal activities, including the vast majority of excitatory neurotransmission in the brain, neuronal migration, synaptogenesis, neuronal plasticity, survival, excitotoxicity and lactate-mediated metabolic coupling between neurons and astrocytes 14, 15 . Through these activities NMDA receptors (NMDARs) play roles in long-term memory consolidation, the development of drug addiction, pain perception, and the pathogenesis of neurological disorders 15 .
While NMDARs are mainly present in neurons, recent studies indicate that NMDAR subunits are also expressed in non-neuronal tissues 16, 17 . Moreover, high expression of NMDAR is present in various types of cancers, such as human neuroblastoma, breast cancer, small-cell lung cancer and ovarian cancer 18, 19, 20, 21 . Although NMDARs have been extensively studied in the brain, their role in nonneuronal tissues or cancer cells is poorly defined. While there are seven different NMDAR subunits in mammals, Drosophila encodes only two NMDAR subunits (NR1 and NR2), which simplifies their study.
Our analyses using anti-NR2 antibody staining ( Figure S1A ) and translational reporter of NR2 (NR2::GFP) ( Figure S1B ), confirmed that NR2 is not only expressed in the Drosophila central nervous system 22, 23 but also in a wide range of developing tissues such as imaginal eye-, and wing discs as well as salivary gland and fat body (Figure S1A-S1C), which is consistent with previously published RNAseq data 17 .
To study the role of NR2 in cell competition in wing discs, we generated mosaic tissues of two clonal populations. This confronts wild-type cells (WT) with clones of cells in which the gene-of-interest (goi) is depleted by RNAi ( Figure 1A Homotypic clonal analysis demonstrated that the growth rate of NR2 clones is equivalent to the one of control LacZ cells ( Figure 1G ), highlighting that NR2 depletion does not impair cell viability or growth in general. Further, treatment with AP5 ((2R)-amino-5-phosphonopentanoate), a selective inhibitor of NR2 26 , suppressed the elimination of NR2 clones in a heterotypic genetic background (losers among winners) ( Figures 1H and 1I ), phenocopying a homotypic setting. This illustrates that the competitive behaviour between NR2-losers and WT-winners is due to a relative difference in NR2 activity among competing clones. AP5-medited global inhibition of NR2 thereby seems to eradicate the "fitness disparity" among competing clones. Together, out data demonstrate that depletion of NR2 does not inherently compromise cell viability. However, when surrounded by WT cells, NR2-depleted cells are recognized and actively eliminated.
Elimination of NR2 loser clones via apoptosis is dependent on the TNF>JNK-signalling axis
To study the elimination process of NR2-depleted cells, we examined the possible involvement of the Grindelwald>JNK signalling axis 27 . While NR2-depleted cells were readily eliminated, such loser clones survived upon simultaneous clonal depletion of the Drosophila TNF-receptor superfamily member Grindelwald (Grnd) (Grnd-RNAi), hemipterous (hep) (hep-RNAi) or inactivation of basket (bsk) (UASbsk-dominant negative (DN)), demonstrating that NR2 clones are eliminated in a Grnd-and JNKdependent manner (Figure 2A ). Consistent with an involvement of JNK signalling, we found intense staining of activated JNK [p-JNK] ( Figure 2B ), induction of the JNK activity reporter PucLacZ ( Figure   S3A ) and high expression level of the JNK target gene MMP1 (JNK target) in and around NR2 clones ( Figure 2C ). JNK signalling in NR2 clones ultimately resulted in caspase-mediated cell death because expression of the caspase inhibitors p35 and DIAP1 suppressed the elimination of NR2 clones ( Figure   2A ). Consistently, we observed cells positive for cleaved caspase staining with anti-cleavedDCP1 (anti-cDCP1) ( Figure S3B ).
JNK-mediated inactivation of PDH in loser cells induces aerobic glycolysis and lactate
production JNK signalling can lead to activation of the mitochondrial Pyruvate Dehydrogenase Kinase (PDK), which in turn can phosphorylate and inactivate Pyruvate Dehydrogenase (PDH), a key enzyme that catalyses the oxidative decarboxylation of pyruvate to produce acetyl coenzyme A, NADH and CO2 28 .
Phospho-dependent inactivation of PDH decreases mitochondrial activity and enhances the conversion of pyruvate to lactate in the cytosol 29 . To test whether depletion of NR2 results in metabolic reprogramming, we monitored the phosphorylation status of PDH. As shown in Figure 3A Enhanced p-PDH staining was strictly JNK-dependent as inhibition of JNK signalling abrogated p-PDH staining ( Figure 3A ). Consistent with PDH inactivation in NR2-RNA clones, we noticed a decreased average size of mitochondria ( Figure S4D) ).
Next, we tested the importance of PDK and p-PDH for the elimination of NR2-RNAi loser clones.
Intriguingly, co-depletion of PDK completely rescued the elimination of NR2-loser clones (Figures 3B
and 3C) and abrogated the appearance of cleaved DCP1 positive cells ( Figure S4E ). Likewise, Gal4driven expression of PDH in NR2-loser clones blocked their elimination ( Figures 3B and 3C ). In both settings, surviving NR2-clones were negative for anti-p-PDH staining ( Figure 3B ). Together, these data indicate that PDK-mediated phosphorylation and inactivation of PHD is required for the death of NR2loser clones.
Loser cells die by 'donating' their lactate to winners
Since inactivation of PDH results in aerobic glycolysis, we assessed whether metabolic reprogramming of loser cells might contribute to their elimination. During aerobic glycolysis, most glucose carbon is converted to pyruvate via glycolysis and reduced to lactate via lactate dehydrogenase (LDH) 30 , which is then secreted. While lactate exits cells via monocarboxylate transporter (e.g. MCT1) to avoid acidification, it can be recaptured and used as source of energy by neighbouring cells, leading to metabolic compartmentalisation between adjacent cells 4, 31 . To test the involvement of lactate exchange from losers to winners during cell competition, we exposed flies to food containing lactate (Llactic acid, LLA). We hypothesised that lactate feeding might flatten a putative lactate gradient between losers and winners and hence block cell competition. Intriguingly, lactate feeding blocked the elimination of NR2-loser clones ( Figures 4A and 4B ). Consistent with the notion that lactate transport from NR2losers to winners is important for loser/winner relationships and cell competition, we found that blocking loser cells to produce and transport lactate to winner cells rescued loser cell elimination. Accordingly, concomitant down-regulation of the lactate dehydrogenase ImpL3 in NR2 loser clones, like coknockdown of the lactate transporter monocarboxylate transporter 1 (Mct1), completely rescued NR2 clone elimination ( Figures 4A and 4B ). This effect was specific to MCT1, as silencing the putative monocarboxylate transporters CG13907 or CG3409 within loser clones had no effect on NR2-loser cell elimination ( Figure 4B ). Pharmacological inhibition of MCT1 also blocked cell competition and the elimination of NR2 loser clones ( Figures 4A and 4B ). Consistent with these results, we observed elevated levels of MCT1 in NR2-RNAi cells ( Figure S5 ). Together, these data suggest that preventing loser cells from transferring lactate to their neighbours may remove fitness disparities and inhibit cell competition.
NR2 is essential for the supercompetitior status of Myc-and RasV12-expressing cells
In mosaic wing imaginal discs, interactions between WT and Myc-or RasV12-expressing cells cause oncogene expressing cells to acquire 'supercompetitor' behaviour that increases their fitness and enables them to overtake the tissue by killing their WT neighbours 32, 33 . To test the potential role of NR2 for the suppercompetitor status of Myc-expressing cells, we first examined the levels of NR2 in Myc clones. As shown in Figures 5A and 5B Myc supercompetitor clones exhibited significantly higher levels of NR2 than surrounding wild-type neighbours, both in the wing disc as well as fat body.
Moreover, such Myc supercompetitor clones also had higher levels of the ligand for NR2, Glutamate ( Figure 5C ).
To test whether NR2 contributes to the supercompetitor status of oncogenic Myc, we depleted NR2 in Myc supercompetitor clones. While clonal expression of oncogenic Myc on its own resulted in large hyperplastic clones, such Myc winners were eliminated when NR2 was simultaneously knocked down in these clones ( Figures 6A and 6C ). Likewise, clones expressing oncogenic RasV12 were also eliminated when NR2 was depleted in RasV12 clones ( Figures 6B and 6C ). Further, we found that depletion of NR2 in RasV12 clones not only eliminated RasV12 clones but also rescued pupal lethality, which is associated with the neoplastic growth of RasV12 clones and the development of RasV12 tumours ( Figure 6D ). Together, these data demonstrate that the supercompetitor status of Myc, and the potential of RasV12 cells to form tumours, critically depends on the presence of NR2. Importantly, Mycand RasV12-expressing NR2 clones were eliminated only in heterotypic settings, when surrounded by WT cells. Accordingly, tissue-wide (nub-Gal4) expression of Myc;NR2-RNAi or RasV12;NR2-RNAi did not lead to the elimination of GFP+ pseudo-clones, demonstrating that such Myc;NR2-RNAi and RasV12/NR2-RNAi clones are intrinsically viable ( Figure 6E ), but when surrounded by WT cells are eliminated via cell competition and caspase-mediated cell death ( Figure 6F ).
Next, we monitored the p-PDH (metabolic reprogramming) status in WT and Myc or RasV12 supercompetitor cells to assess whether lactate-mediated metabolic coupling might be important for loser/supercompetitor relationships. Under homotypic conditions, no p-PDH staining was apparent in WT cells ( Figure S6A and Figure S7 Figure 4A ), this then results in the transfer of lactate from losers to their neighbours, providing them with winner status. Hence, altered metabolism of loser cells may be due to lower NR2 activity. Together, our data suggest that NR2-mediated regulation of metabolism may influences cell competition.
Discussion
The active elimination of unfit cells via competitive interactions plays an important role for the maintenance of tissue health during development and adulthood 1, 2, 34, 35, 36 . Our data indicate that the activity of NR2 influences the competitive behaviour of epithelia cells and Myc or RasV12 supercompetitors. We find that pharmacological inhibition or genetic depletion of NR2 reprograms metabolism via TNF-dependent and JNK-mediated activation of PDK, which in turn phosphorylates and inactivates PDH. This causes a shutdown of pyruvate catalysis and results in a switch to aerobic glycolysis. In the absence of functional PDH, pyruvate is reduced to lactate via LDH, and secreted 30 .
Disposal of this large carbon pool as lactate serves multiple functions. While lactate exits cells to avoid acidification, it can be recaptured and used as carbon source by other cells, leading to metabolic compartmentalisation between adjacent cells. In normal physiology as well as in murine and human tumours, lactate is an important energy source that fuels mitochondrial metabolism 4, 31 . For example, lactate produced and secreted by astrocytes is transported to neighbouring neurons where it is used as source of energy to support neuronal function 14 . This is akin of the 'reverse Warburg effect' 6 , also named 'two-compartment metabolic coupling' model, where cancer-associated fibroblasts (CAFs) undergo aerobic glycolysis and production of high energy metabolites, especially lactate, which is then transported to adjacent cancer cells to sustain their anabolic need 6 .
Our data suggest that epithelial NMDA receptor activity is responsible for fitness surveillance and to provide clones with oncogenic mutations supercompetitor status. Cells with decreased epithelial NMDA receptor activity become classified as 'less fit' and are metabolically reprogrammed to donate their carbon fuel to their neighbours, rendering them 'fitter'. According to our model, differential NMDAR signalling in adjacent cells triggers lactate-mediated metabolic coupling, and underpins cell competition in epithelia. Consistently, preventing loser cells from 'donating' lactate to their neighbours removes the fitness disparity and nullifies cell competition. Likewise, exposure to elevated levels of systemic lactate, such as upon lactate feeding, completely blocks elimination of NR2 loser clones, most likely because excessive lactate exposure 'flattens' the fitness disparity. This suggests that cell competition may be based on NMDAR-mediated metabolic coupling between winners and losers. Importantly, this metabolic coupling only occurs if adjacent cells have differential NMDAR signalling. Consistently, NR2 losers are only eliminated if they are surrounded by cells with functional NMDAR. This is evident as tissue-wide inhibition of NMDAR by AP5, a selective inhibitor of NR2, blocks elimination of NR2 loser clones in a heterotypic genetic setting.
Like in flies, NMDAR also seems to be upregulated in genetically engineered mouse models of cancer, where it induces an autocrine glutamate signalling circuit with resultant stimulation of malignancy 21 .
Furthermore, the NMDAR pathway is evident in various human tumours and cell lines, and its expression level is associated with poor cancer patient prognosis 21 . We find that NR2 is upregulated in Myc expressing clones and that such cells co-opt epithelial NR2 to promote cell competition, subduing their neighbouring wild-type cells that become re-classified as 'unfit'. Given that Myc is a major driver of cancer cell growth, and is a hallmark of the disease in nearly seven out of ten cases, blocking Myc's function would be a powerful approach to treat many types of cancer. However, the properties of the Myc protein itself make it difficult to design a drug against it. We now find that inactivating NR2 in Myc or RasV12 clones kills these cells in a strictly cell competition-dependent manner.
Together, our data suggest that Myc and RasV12 clones critically depend on the activity of NR2 for their supercompetitor status, and that NR2 could serve as an attractive therapeutic target against various types of cancers that have deregulated levels of NR2, with no apparent effects on homotypic wild-type neighbours. This highlights new vulnerabilities of clones with oncogenic mutations, and may pave the way for new anti-cancer treatment approaches that are based on cell competition.
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Hogan-Cann AD, Anderson CM. allowed to lay eggs in fresh tubes for 3 hours. 72 hours after egg laying (AEL) larvae were incubated at 37 °C for 10 minutes to induce transgene expression. Following temperature shift, animals were kept at 24 °C. Imaginal wing discs were dissected 48 hours after heat-shock-mediated induction of clones.
METHODS
For the experiment shown in Figure 3D , clones were induced as above. After clone induction, flies were raised for 10 days at 24 °C. The numbers of eclosed imagoes and dead pupae were counted and the ratio of imago/total per vial was calculated. Quantifications. Imaginal discs were imaged at 20x magnification. Seven Z-stacks were taken for each disc. After imaging, channels were split and maximum Z-projection was analysed. Using DAPI channel images, a line was drawn around the pouch area and measured using ImageJ. The sum areas of GFPpositive clones were measured using the GFP channel. Threshold was adjusted with the Huang autotresholding algorithm to subtract background. The area above the threshold was analysed. Data were collected from at least three independent experiments, and 10 wing discs per genotype and/or condition were analysed, unless stated otherwise. The relative occupancy of GFP positive clones was quantified, and expressed as proportion of GFP-positive clones per pouch (± S.D.).
Statistics and data presentation. All statistical analyses were carried out using GraphPad Prism7. Table for genotypes. Table for genotypes. throughout the wing pouch as described in Figure 1B Antibody staining with anti-NR2 antibodies in salivary glands in which NR2 was downregulated in clones. RNAi clones are marked by GFP. Scale bar 100 μm. See Supplemental Information Table for genotypes.
Comparisons between two genotypes/conditions
Figure S2. Context-dependent elimination of loser clones.
(A) Heterotypic clonal analysis. The indicated genes were knocked down in GFP-marked clones as depicted in Figure 1D . Scale bar 100 μm. (B) Homotypic clonal analysis. Dlg1 was knocked down throughout the wing pouch as described in Figure 1F . GFP-marked clones represent pseudo-clones.
Scale bar 100 μm. (C) Homotypic analysis. The indicated genes were knocked down throughout the posterior compartment of the wing pouch. Scale bar 100 μm. See Supplemental Information Table for genotypes. Confocal images of third instar imaginal wing discs that were immunostained for cleaved DCP1 as a readout of caspase activation and apoptosis. Scale bar 50 μm. See Supplemental Information Table for genotypes. Figure S5 . MCT1 is upregulated in NR2 loser clones.
Confocal images of anti-MCT1 stained wing pouches. Scale bar 20 μm. See Supplemental Information Confocal images of dissected wing pouches stained for anti-phospho-PDH. Scale bar 20 μm. b, Fluorescent intensities of phospho-PDH (black) and GFP (green) are measured by ImageJ software at the yellow lines. 
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